NCT01297569
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
- Locations
-
- Novartis Investigative Site Oslo, Norway
Clinical trial condition
Diabetic Retinopathy
Explore clinical trials studying Diabetic Retinopathy. Study availability and eligibility vary by location and protocol.
482 public trials
67 recruiting studies
Diabetic Retinopathy trial results
NCT01744132
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +9 more
- Locations
-
- Jefferson Pharmacy Philadelphia, Pennsylvania, United States
NCT01506895
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +7 more
- Locations
-
- GSK Investigational Site Parramatta, New South Wales, Australia
- GSK Investigational Site Sydney, New South Wales, Australia
- GSK Investigational Site East Melbourne, Victoria, Australia
- GSK Investigational Site Nedlands, Western Australia, Australia
NCT01622816
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- Mid Atlantic Retina- Wills Eye Institute Philadelphia, Pennsylvania, United States
Completed
Tracking Optical Coherence Tomography
NCT00343603
- Conditions
- Cardiovascular Diseases, Choroid Diseases, Choroidal Disease, +13 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT02927561
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- Retina Clinic São Paulo, Brazil
NCT00090519
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Artesia, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palm Springs, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poway, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Walnut Creek, California, United States
NCT00266695
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test Mesa, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test Huntington Beach, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test Orange, California, United States
NCT00604383
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT -5 hours, EST) or speak with your personal physician. Indianapolis, Indiana, United States
Completed
Study of Topical Ocular PAN-90806 in PDR
NCT02475109
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +6 more
- Locations
-
- Valley Retina Institute Harlingen, Texas, United States
- Valley Retina Institute McAllen, Texas, United States